[Changes in the hemodynamic indices of hypertension patients]. 1983

L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
July 1983, Vrachebnoe delo,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
January 1996, Likars'ka sprava,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
January 1982, Vrachebnoe delo,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
January 1971, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
September 1972, Kardiologiia,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
January 1973, Vutreshni bolesti,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
March 1981, Kardiologiia,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
August 1987, Vrachebnoe delo,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
November 1976, Kardiologiia,
L A Shvedenko, and A P Parashchak, and S T Iurkevich, and M D Neporadnyĭ, and P V Bigar'
January 1976, Pediatriia akusherstvo i ginekologiia,
Copied contents to your clipboard!